Chemoinformaics analysis of GANOLUCIDIC-ACID-A
| Molecular Weight | 500.676 | nRot | 6 |
| Heavy Atom Molecular Weight | 456.324 | nRig | 24 |
| Exact Molecular Weight | 500.314 | nRing | 4 |
| Solubility: LogS | -4.752 | nHRing | 0 |
| Solubility: LogP | 2.946 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 84.2509 |
| nHD | 2 | BPOL | 47.6131 |
| QED | 0.521 |
| Synth | 4.998 |
| Natural Product Likeliness | 3.202 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.307 |
| Pgp-sub | 0.004 |
| HIA | 0.066 |
| CACO-2 | -5.378 |
| MDCK | 0.0000197 |
| BBB | 0.977 |
| PPB | 0.844711 |
| VDSS | 0.466 |
| FU | 0.0783626 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.487 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.93 |
| CYP2c9-inh | 0.046 |
| CYP2c9-sub | 0.944 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.246 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.234 |
| CL | 14.94 |
| T12 | 0.687 |
| hERG | 0.002 |
| Ames | 0.019 |
| ROA | 0.116 |
| SkinSen | 0.018 |
| Carcinogencity | 0.062 |
| EI | 0.011 |
| Respiratory | 0.935 |
| NR-Aromatase | 0.524 |
| Antiviral | Yes |
| Prediction | 0.736171 |